Evidence-based Tactics Impact TRx Growth

Author: and

Co-pay and adherence programs continue to be the most effective tactics to drive TRx pull through

Many pharmaceutical companies use co-pay cards and adherence programs as individual tactics in their patient support programs, but health care consultancies Best Practices, LLC and RxSolutions believe that tandem use can mean higher TRxs, lower total cost of care, and an improvement in patients’ lives.

RxSolutions’ work with pharma companies revealed that the combination of a co-pay card linked to an adherence program creates win-win results. In a recent case, TRxs increased 43% while fills per patient increased 19%, according to David Lengacher, Vice President of Analytics at RxSolutions.

See the full story here:

In addition to evidence found in TRx data, recent survey research conducted by Best Practices saw co-pay assistance rated as the most effective patient support tool, with 71 percent of companies rating it as highly effective.

“As payers place more emphasis on outcomes data and look at total cost of care in determining formularies, co-pay programs remain crucial to getting medicines prescribed and make it easier for patients to get into a routine of taking their medicines,” said Cameron Tew, Head of Research Services at Best Practices, LLC. “If better medication maintenance has become a key consideration for payers, then co-pay cards should be a primary tool that pharma companies employ.”

In a clear example of such effectiveness, RxSolutions helped one company grow its total prescriptions by 82 TRx for every 100 co-pay card redemptions leading to a 21 percent increase in revenue.

To learn more about the effectiveness of co-pay cards and adherence programs in an overall patient support plan, you can download a short case study here on changing prescriber & patient behavior as well as patient support benchmarks.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: